Product Information
LACOSAMIDE 200 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2767 per EA under NDC 68462068160. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
200 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462068160
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205006On Market Since
3/18/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 200 MG TABLET has been published 210 times since Jun 22, 2022, and over the history we have for it it has declined 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2767 per EA |
|---|---|
| All-time high | $0.5448 (Jul 13, 2022) |
| All-time low | $0.2531 (Nov 20, 2024) |
| 52-week high | $0.3088 |
| 52-week low | $0.2767 |
| Median price | $0.3816 |
| Average price | $0.3714 |
| Largest weekly change | +31.5% (Aug 21, 2024) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 200 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2767 per EA (NDC 68462068160), effective Jun 24, 2026.
How has the price of LACOSAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 200 MG TABLET has declined 49.2%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 200 MG TABLET?
Since Jun 22, 2022, the NADAC for LACOSAMIDE 200 MG TABLET has ranged from a low of $0.2531 (Nov 20, 2024) to a high of $0.5448 (Jul 13, 2022), with a median of $0.3816 per EA.
Are there cheaper alternatives to LACOSAMIDE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LACOSAMIDE 200 MG TABLET, but none are currently priced below it.
Who manufactures LACOSAMIDE 200 MG TABLET?
LACOSAMIDE 200 MG TABLET (NDC 68462068160) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification